Mary M. Rozenman, See Remarks at Aimmune Therapeutics, Inc. (AIMT), sold 13,182 shares at $37.08 ($489K) on 2018-01-02, disclosed to the SEC on 2018-01-04.
Open-market sale of $489k AIMT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.08 | 1,601 | $59K | 12.1% |
| 2 | $37.08 | 1,601 | $59K | 12.1% |
| 3 | $37.12 | 4,990 | $185K | 37.9% |
| 4 | $37.12 | 4,990 | $185K | 37.9% |
| Total | $37.11 avg | 13,182 | $489K | 100% |
| Filing → |
| AIMT | SELL | 2017-12-28 | $381K | — | Filing → |
| AIMT | SELL | 2017-09-11 | $675K | — | Filing → |
| AIMT | SELL | 2017-07-17 | $320K | — | Filing → |